Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cerebral vasospasm. Experimental study].

B K Weir1

  • 1Division of Neurosurgery, University of Alberta, Edmonton, Canada.

Neuro-Chirurgie
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Chronic vasospasm in primates is linked to cerebral artery clots. Early clot removal or treatments like aminosteroid U 74006F and plasminogen activator can reduce vasospasm severity and prevent brain damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The vasorelaxation of cerebral arteries by carbon monoxide.

Experimental biology and medicine (Maywood, N.J.)·2001
Same author

Phosphatidylcholine peroxidized by hemoglobin increases intracellular calcium in dog basilar artery smooth muscle cells.

Acta neurochirurgica. Supplement·2001
Same author

Role of adenosine 5'-triphosphate in vasospasm after subarachnoid hemorrhage: human investigations.

Neurosurgery·2001
Same author

Hemoglobin increases endothelin-1 in endothelial cells by decreasing nitric oxide.

Biochemical and biophysical research communications·2001
Same author

Multimedia computer database for neurosurgery.

Neurosurgery·2000
Same author

Effects of posterior fossa decompression with and without duraplasty on Chiari malformation-associated hydromyelia.

Neurosurgery·2000
Same journal

Full-endoscopic uniportal wiltse paraspinal approach with inferior foraminal docking for extraforaminal lumbar disc herniation and foraminal stenosis: technical note and preliminary clinical outcomes.

Neuro-Chirurgie·2026
Same journal

Beyond "Time to Surgery": a structured evidence review and multi-clock framework for emergency cranial neurosurgery.

Neuro-Chirurgie·2026
Same journal

Clinical predictors of overall survival in very elderly patients with spinal osteosarcoma: an analysis of the surveillance, epidemiology, and end results database.

Neuro-Chirurgie·2026
Same journal

Advances in tailored intraparenchymal delivery of regenerative medicine for spinal cord injury: a review of preclinical studies and clinical trials.

Neuro-Chirurgie·2026
Same journal

The renal involvement during lateral lumbar interbody fusion: a radioanatomical study for surgical risk stratification.

Neuro-Chirurgie·2026
Same journal

Chronic inflammatory involvement of the sacral multifidus insertion, predominantly observed after lumbar surgery.

Neuro-Chirurgie·2026
See all related articles

Area of Science:

  • Neurology
  • Vascular Biology
  • Pharmacology

Context:

  • Chronic vasospasm (V.S.) is a significant complication following subarachnoid hemorrhage (SAH).
  • Adherent clots in cerebral arteries are implicated in V.S. development and can lead to cerebral infarction.
  • Free radicals and lipid peroxidation contribute to cerebral ischemia.

Purpose:

  • To investigate the mechanisms of chronic vasospasm in a primate model.
  • To evaluate the efficacy of interventions in mitigating V.S. and related ischemic events.
  • To explore the role of clot lysis and antioxidant therapies in preventing V.S.

Summary:

  • Vasospasm is associated with adherent clots, and their removal within 48 hours post-SAH reduces V.S. intensity.
  • The aminosteroid U 74006F acts as a free radical scavenger, reducing V.S. histological changes after SAH.

Related Experiment Videos

  • Plasminogen activator, administered within 72 hours post-SAH, can prevent V.S., potentially by managing oxyhemoglobin levels from red blood cell hemolysis.

    • Impact:

    • Findings suggest therapeutic strategies for preventing or treating vasospasm after SAH.
    • Early intervention with clot removal or specific pharmacological agents shows promise in reducing neurological damage.
    • Understanding the role of free radicals and clot-induced oxyhemoglobin is crucial for developing novel treatments.